Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Agria Pet Insurance and Pets4Homes announce new partnership

A new partnership has launched between Agria Pet Insurance and Pets4Homes, with the welfare-focused lifetime pet insurer to feature prominently on Pets4Homes.co.uk. In this Financial Conduct Authority approved agreement, the opportunity to protect pets with insurance is now integrated into the very start of the buying process.Access to five weeks’ free insurance with Agria via the new Pets4Homes Pet Payments service gives dogs and cats the protection of insurance right from the beginning of life with their new owners. Pet Payments on Pets4Homes is a secure online payment system that aims to

Notification under Chapter 9, Section 10 of the Finnish Securities Market Act

Neste Corporation, Stock Exchange Release, 14 August 2024 at 9:45 a.m. (EET)Neste Corporation has yesterday received a notification under Chapter 9, Section 10 of the Finnish Securities Market Act (FSMA). According to the notification by BlackRock, Inc., the aggregate holdings of the entities referred to therein excluding financial instruments according to SMA 9:6a have on 12 August 2024 decreased to below 5% of the total number of shares and voting rights of Neste Corporation. The aggregate holdings including financial instruments according to SMA 9:6a owned by BlackRock, Inc. and the

NYAB AB’s Interim Report January-June 2024: Improvement and development

April-June in brief · Revenue amounted to EUR 76.1 (65.3) million, representing a change of 16.5%. In constant currencies, revenue growth was 16.8%. · Operating profit (EBIT) was EUR 3.8 (4.0) million, amounting to 5.0% (6.2%) of revenue. In the comparison period, EBIT was benefited by EUR 3.3 million related to the settlement of Mikkeli dispute in Finland. · Free cash flow was EUR -1.0 (8.4) million. In the comparison period, free cash flow was benefited by EUR 9.2 million related to the settlement of Mikkeli dispute. · Net debt/EBITDA was -0.31 (0.19). · Order backlog

Genova Property Group Interim report January–June 2024

January–June period 2024 · Rental income amounted to SEK 262.1m (254.5), an increase of 3%. · Net operating income amounted to SEK 191.1m (186.4), an increase of 3%. · Income from property management amounted to SEK 56.6m (24.1), an increase of 135%, of which income from property management attributable to shareholders was SEK 18.6m (-15.2), corresponding to SEK 0.41 (-0.33) per share. · Net income for the period amounted to SEK 59.6m (-148.3), corresponding to SEK 0.47 (-3.68) per share. The increase was mainly due to improved changes in the value of properties. · Long-

Klaria Sumatriptan Alginate Film Receives Marketing Authorization

Klaria has been notified by the German Federal Institute for Drug and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM) that the review process has concluded, and that marketing authorization for the treatment of migraine with and without aura is granted.The review process was led by the German Federal Institute for Drug and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM) and applies to markets in Germany, Italy, and Spain.  Further authorizations within the EU will be through the Mutual Recognition Procedure (MRP) and Repeat Use

Positive Phase 3 Results in Hidradenitis Suppurativa Further Strengthen Competitive Profile of Izokibep

• Phase 3 trial of izokibep in patients with hidradenitis suppurativa met primary endpoint of HiSCR75 at week 12, as well as the key secondary endpoints of HiSCR90 and HiSCR100.• Data from two-thirds of trial participants who have completed week 16 demonstrate deepening of responses over time.• No new safety signals were identified, and the favorable safety profile demonstrated in previous trials was confirmed. Stockholm, Sweden, August 13, 2024. Affibody’s partner ACELYRIN, INC. today announced that the Phase 3 trial of the Affibody® molecule izokibep in patients with hidradenitis

Best July Ever for First Camp

First Camp, Scandinavia's largest camping chain, achieved its best-ever revenue performance in July. Moreover, July was the first month ever where total reported turnover exceeded half a billion SEK.July is the most important month for the Scandinavian camping industry. In July, First Camp reached a Group turnover of 516 million SEK, the highest ever. Even on a pro forma basis, meaning excluding the impact of acquisitions, revenues were higher than both July 2023 and the previous peak year of 2022. It is particularly gratifying to see that the growth from 2023 is mainly driven by more

DanCann Pharma A/S: Quarterly CEO Reflection

COPENHAGEN, Denmark, 14 August 2024 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby announces the CEO’s reflections following the publication of the Company’s Q2-2024 report.CEO, Jeppe Krog Rasmussen, comments:   Financials: Record revenue and positive EBITDA DanCann Pharma closed Q2-2024 with a record revenue of DKK 3.86 million. For H1-2024, this resulted in a further record revenue of approximately DKK 4.55 million. Comparing this to the revenue of DKK 2.90 million for H1-2023, we have amassed an increase of

2020 Bulkers Ltd. (2020) – Commercial update and key information relating to the dividend for July 2024

Oslo, Norway, August 14, 2024 Commercial update: In July 2024, the Company achieved average time charter equivalent rate (“TCE")* of approximately US$37,600 per day, gross, for the Company’s vessels trading on index-linked time charter including average daily scrubber benefits of approximately US$2,900 per day. The Company had 186 operational days in July 2024. The Baltic 5TC Capesize Index averaged US$25,542 during July 2024. *Average time charter equivalent rate, gross, (“TCE") when used by the Company, means time charter revenues and voyage charter revenues excluding address

Invitation to conference call with web presentation of AcadeMedia's full year result for July - June 2023/24

AcadeMedia's full year result for July - June 2023/24 will be published at 08:00 CEST on 28 August. A web-cast telephone conference will be held at 09:30 CEST the same day, where CEO Marcus Strömberg and CFO Petter Sylvan will present the report. The presentation and following Q&A session will be held in English. To participate in the conference call please register via this link: https://conference.financialhearings.com/teleconference/?id=50049871 After registration, you will be provided with telephone numbers and a conference ID to access the conference. You can ask questions

Ruukki and Nrep Logicenters to deliver unique logistics center in Finland using Ruukki LowCarbon products

Ruukki ConstructionPress release14 August 2024 at 9 am EESTRuukki Construction, part of SSAB, has signed an agreement with real estate investor Nrep’s logistics arm Logicenters to deliver a unique logistics center in Tampere. The lifecycle emissions of the building will be significantly smaller than usual, as the walls will be made of innovative Ruukki® LowCarbon products. Ruukki will supply sandwich panels and design profiles in the Ruukki® LowCarbon product family to a logistics center that Logicenters is building in Tampere, Finland. The installation contractor for the steel

Flexion and King Team Up to Launch First Game on Alternative App Stores

LONDON – 14 August, 2024 - Flexion (NASDAQ:FLEXM.ST ), the games marketing company, has launched King’s global hit game Candy Crush Saga[©] on the alternative app stores: Huawei App Gallery, Samsung Galaxy Store, Xiaomi GetApps and ONE store. Flexion’s distribution services will help enable King to reach new players from alternative app stores. “We are delighted that King chose Flexion, and it’s an honour to take one of the world’s most successful mobile games to the alternative app stores,”

Metso signs EUR 200 million frame agreement for key process equipment deliveries to Reko Diq copper-gold project

Metso Corporation’s press release on August 14, 2024, at 09:00 a.m. EESTMetso has signed a comprehensive frame agreement with Reko Diq Mining for key process equipment deliveries to the company’s greenfield copper-gold project in the province of Balochistan in Pakistan. Reko Diq is one of the largest undeveloped copper-gold deposits in the world. The gross value of the various Metso equipment packages under the framework agreement is EUR 200 million. The value of the first orders, consisting of crushing and grinding equipment, is close to EUR 100 million in total, and they are booked in

First Camp Group Interim report Q2 2024

First Camp, Scandinavia’s largest campsite chain, increased revenues in the second quarter of 2024 by ten percent vs same period in 2023, adjusted for effects from acquisitions (pro forma) and excluding the calendar effect of an earlier Easter.Second quarter 2024 (same quarter last year in brackets) · Total revenue of SEK 305.3 million (285.5) · Pro forma revenue increased with 5% compared to Q2 2023 · Pro forma Adjusted EBITDA amounted to SEK 37.3 million (38.6) · EBIT of SEK 12.3 million (-4.7) · Cash flow from operating activities of SEK 116.0 million (121.3) First

Moody’s confirms that Outokumpu’s Ba2 corporate family rating and stable outlook remains unchanged

Outokumpu CorporationPress releaseAugust 14, 2024 at 9.00 pm EESTMoody’s confirms that Outokumpu’s Ba2 corporate family rating and stable outlook remains unchanged Moody’s has reviewed Outokumpu’s credit rating and confirms that the Ba2 corporate family rating and stable outlook remains unchanged. In May 2023, Moody’s upgraded Outokumpu’s corporate family rating to Ba2 from the previous rating of Ba3 and changed the outlook on the rating from positive to stable. “We are very pleased that Moody’s recognizes Outokumpu’s strong financial position and our profit improvement

Cloudberry Clean Energy ASA | Invitation to presentation of second quarter 2024 results

Oslo, Norway, 14 August 2024: Cloudberry Clean Energy ASA (“Cloudberry” or the “Company”) will publish its second quarter results on 21 August 2024 at 07:00 CEST. The company management will host a presentation and Q&A session the same day at 11:00 CEST.Please use the following link to access the live presentation and Q&A session: https://tv.streamfabriken.com/cloudberry_clean_energy_asa_q2_2024 The second quarter 2024 report and presentation material, and the link/recording to the webcast will be made available at www.cloudberry.no.For further information, visit our company and IR

SKF makes strategic acquisition to strengthen its lubrication management capabilities

Gothenburg, 14 August 2024: SKF has signed an agreement to acquire John Sample Group’s (JSG) Lubrication and Flow Management businesses. JSG is a well established provider of lubrication management systems and services. The acquisition further strengthens SKF’s offering in an identified growth segment, as well as its business operations in the expansive India and South-East Asia (ISEA) region. More than half of all premature bearing failures are caused by poor lubrication and contamination. This means that lubrication is a critical aspect in machine reliability with a direct and profound

2020 Bulkers Ltd. (2020) - Results for the second quarter of 2024

Oslo, Norway, August 14, 2024 2020 Bulkers Ltd. (“2020 Bulkers” or the “Company”), today announced its unaudited financial and operating results for the three and six months ended June 30, 2024. Key events during the second quarter of 2024 · The Company reported net profit of US$31.1 million and EBITDA of US$34.4 million for the second quarter of 2024. The results include a US$20.4 million gain from the sale of Bulk Seoul which was delivered to the buyer on April 4, 2024. · Achieved average time charter equivalent earnings of approximately US$34,300 per day, gross. ·

Patrick Höijer appointed New CEO of Foxway

The Board of Directors of Foxway announces the appointment of Patrick Höijer as new CEO. The leadership change is part of a transition to better prepare the company for the next chapter of growth. Patrick Höijer will succeed Martin Backman, Foxway’s Co-Founder, who will assist during a transitional period and remain a shareholder.Foxway is one of the leading circular tech services provider in Europe, its unique positioning helps its customers source and lease IT equipment as well as refurbish and resell used devices. Since its foundation in 2009, Foxway, headquartered in Sweden, achieved a

Patrick Höijer appointed New CEO of Foxway

The Board of Directors of Foxway announces the appointment of Patrick Höijer as new CEO. The leadership change is part of a transition to better prepare the company for the next chapter of growth. Patrick Höijer will succeed Martin Backman, Foxway’s Co-Founder, who will assist during a transitional period and remain a shareholder.Foxway is one of the leading circular tech services provider in Europe, its unique positioning helps its customers source and lease IT equipment as well as refurbish and resell used devices. Since its foundation in 2009, Foxway, headquartered in Sweden, achieved a

Genetic Analysis directed issue to major shareholders has now been registered with the Norwegian Register of Business Enterprises

Genetic Analysis AS' (“GA” or the “Company”) directed issue to current major shareholders and certain members of the board of directors and management has now been registered with the Norwegian Register of Business Enterprises (No. Foretaksregisteret).On July 1 and July 17, 2024, GA carried out the directed issue that provided the Company with NOK 5.42 million by issuance of 7,225,916 new shares, before issue costs. The direct Issue has now been registered with the Norwegian Register of Business Enterprises. After this, the Company's new registered share capital is NOK 29,629,962.60

DanCann Pharma A/S Publishes Q2-2024 Report: Record Revenue and First-Ever Positive EBITDA

COPENHAGEN, Denmark, 14 August 2024 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby announce that the Company has published its report for the second quarter of 2024. The Q2-2024 report is available as an attached document to this press release and at www.dancann.com.SUMMARY: GROUP KEY FIGURES Q2-2024 +-----------+----------+----------+----------+----------+-------------------+|DKK 1,000 |01/04/24 |01/04/23 |01/01/24 |01/01/23 |01/01/23 - 31/12/23|| |- 30/06/24|- 30/06/23|- 30/06/24|- 30/06/23|

Interim report Q2: We see a number of signs that the worst is now behind us

April – June 2024 · Net sales decreased by 5% and amounted to SEK 858 (907) million · Organic growth amounted to -6 (-10) % · Adjusted EBIT amounted to SEK 48 (74) million with a margin of 5.6 (8.2) % · Cash flow from operating activities amounted to SEK 35 (101) million · Earnings per share for the period before and after dilution amounted to SEK 0.47 (0.72) - Rock Sweden continues to perform well, but the low new housing construction negatively impacts the Foundation Sweden segment. In Norway, we experienced a weaker market than expected in the second quarter, which,

There are no items matching the current filter
There are no more items matching the current filter
Back to top